UNITY Biotechnology
Entity

  • UNITY Biotechnology

    Created in 2009
  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    5,163 8,366

  • Activities

    deeptech biotech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    285 E Grand Ave., South San Francisco, CA 94080, USA

    South San Francisco

    United States of America

  • Employees

    Scale: 51-200

    Estimated: 32

  • Engaged corporates

    2
    1 1

  • Added in Motherbase

    5 years, 10 months ago
Description
  • Value proposition

    UNITY is developing a new class of therapeutics to slow, halt or reverse diseases of aging. UNITY’s current focus is on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related ophthalmologic and neurologic diseases. More information is available at www.unitybiotechnology.com.

  • Unity Biotechnology • Targeting a Root Cause

    At UNITY Biotechnology we are developing therapeutics to slow, halt, or reverse diseases of aging

    • https://unitybiotechnology.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Amazon
Amazon
IT services, Consumer Electronics, Software Development
Amazon
IT services, Consumer Electronics, Software Development 		Other

27 Feb 2018


Nasdaq
Nasdaq
Finance, Financial Services
Nasdaq
Finance, Financial Services 		Not capitalistic
Not partnership
Event

12 Oct 2018


Similar entities
Last news
Show all articles
Social network dynamics